David Shaw’s Edwards Lifesciences EW Stock Holding History

David Shaw’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,700	Closed	-$558K	–	4448
2025 Q1	$558K	Buy	+7,700	New	+$551K	﹤0.01%	3446
2024 Q3	–	Sell	-9,600	Closed	-$887K	–	4627
2024 Q2	$887K	Buy	+9,600	New	+$850K	﹤0.01%	3269
2021 Q1	–	Sell	-102,900	Closed	-$9.39M	–	4169
2020 Q4	$9.39M	Hold	102,900	–	–	0.01%	1421
2020 Q3	$8.21M	Sell	102,900 -30,000	-23%	-$2.34M	0.01%	1370
2020 Q2	$9.19M	Hold	132,900	–	–	0.01%	1236
2020 Q1	$8.36M	Sell	132,900 -17,700	-12%	-$1.28M	0.01%	1099
2019 Q4	$11.7M	Buy	150,600 +10,800	+8%	+$843K	0.01%	1105
2019 Q3	$10.2M	Buy	139,800 +60,000	+75%	+$4.21M	0.01%	1143
2019 Q2	$4.91M	Hold	79,800	–	–	0.01%	1601
2019 Q1	$5.09M	Buy	+79,800	New	+$4.55M	0.01%	1541
2018 Q1	–	Sell	-30,000	Closed	-$1.13M	–	3573
2017 Q4	$1.13M	Hold	30,000	–	–	﹤0.01%	2509
2017 Q3	$1.09M	Hold	30,000	–	–	﹤0.01%	2438
2017 Q2	$1.18M	Hold	30,000	–	–	﹤0.01%	2306
2017 Q1	$941K	Hold	30,000	–	–	﹤0.01%	2333
2016 Q4	$937K	Hold	30,000	–	–	﹤0.01%	2498
2016 Q3	$1.21M	Buy	+30,000	New	+$1.13M	﹤0.01%	2281
2016 Q1	–	Sell	-240,000	Closed	-$6.32M	–	3525
2015 Q4	$6.32M	Hold	240,000	–	–	0.01%	1249
2015 Q3	$5.69M	Hold	240,000	–	–	0.01%	1310
2015 Q2	$5.7M	Hold	240,000	–	–	0.01%	1364
2015 Q1	$5.7M	Hold	240,000	–	–	0.01%	1295
2014 Q4	$5.09M	Buy	240,000 +180,000	+300%	+$3.62M	0.01%	1554
2014 Q3	$1.02M	Buy	+60,000	New	+$947K	﹤0.01%	2795
2013 Q4	–	Sell	-37,200	Closed	-$432K	–	4522
2013 Q3	$432K	Buy	+37,200	New	+$435K	﹤0.01%	3675

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

David Shaw's EW Position: Q1 2026 in Review

David Shaw sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 89,515 shares — an estimated $7.63M sold.

David Shaw first reported a position in EW in Q2 2013 and held it in 45 quarters. The position peaked at $251M in Q1 2023. 1,288 funds tracked by Wall St. Rank hold EW as of Q1 2026.

David Shaw reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
David Shaw sold 89,515 Edwards Lifesciences shares in Q1 2026, an estimated $7.63M.
David Shaw first reported a position in Edwards Lifesciences in Q2 2013 and held it in 45 quarters.
David Shaw's Edwards Lifesciences position peaked at $251M in Q1 2023.
1,288 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.